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Paraneoplastic pemphigus (PNP), described in 1990 
by Anhalt et al. (1), is an autoimmune mucocutaneous 
blistering disease characterized by severe mucosal ero-
sions and polymorphic cutaneous lesions. In 2001 the 
term paraneoplastic autoimmune multi-organ syndrome 
(PAMS) was coined (2) to reflect its frequent multi-organ 
involvement and numerous clinical variants (pemphigus-
like, pemphigoid-like, erythema multiforme-like, graft-
versus-host disease-like, and lichen planus-like). This 
disease is most often associated with haematological 
malignancies, and has a high mortality rate (90%) with 
less than one-year mean survival.
We report here a case of PNP/PAMS that was asso-
ciated with retroperitoneal Kaposi’s sarcoma (KS) and 
evolved through 3 different clinical variants (pemphi-
gus-like, lichen planus-like and erythema multiforme-
like). This is the first report of an association of PNP/
PAMS with KS in literature. 
CASE REPORT
An HIV-negative 70-year-old man was treated with hydroxy-
chloroquine (400 mg per day) for an erosive lichen planus 
involving the tongue, confirmed by histopathology and direct 
immunofluorescence (DIF). One month later, the patient sho-
wed a worsening of the oral ulcerations (Fig. 1a), and vesicles 
and blisters appeared on his trunk and lower limbs (Fig. 1b). 
Histopathology of a skin lesion revealed suprabasal intraepi-
dermal blistering (not shown) and DIF showed intercellular 
deposition of IgG and C3 associated with C3 deposition at the 
basal membrane zone (BMZ) (Fig. 1c). The diagnosis of PNP 
was confirmed by indirect immunofluorescence (IIF) on rat 
bladder and by immunoprecipitation, with reactivity directed to 
the alpha-2-macroglobulin-like-1 (A2ML1) protein (Fig. 1d). 
Hydroxychloroquine was stopped and oral prednisone, at an ini-
tial dosage of 75 mg per day, was introduced with partial response. 
Extensive work-up, including an abdominal computed tomography 
(CT) scan, revealed a mesenteric mass in the peritoneum, below 
the diaphragm and next to the pancreas, with some enlarged lymph 
nodes, suggestive for a lymphoproliferative disorder. Despite treat-
ment with glucocorticoids, the cutaneous blistering and oral ero-
sions worsened. In addition, the patient developed many lilac itchy 
papules on the back and an erythematous purplish hyperkeratotic 
plaque on the inner surface of the left knee. Histopathology and DIF 
of a lilac papule on the patient’s back led to a diagnosis of lichenoid 
dermatitis with C3 and fibrinogen deposit in the cytoplasm of the 
keratinocytes and intercellular deposition of C3. Histopathology of 
the plaque on the knee was also consistent with lichenoid derma-
titis. The patient’s general clinical condition worsened. He deve-
loped respiratory failure suggestive of bronchiolitis obliterans and 
erosive conjunctivitis associated with a polymorphous eruption of 
erythematous targetoid plaques localized on the upper extremities, 
together with a worsening of the oral erosions. Oral prednisone 
was increased to 125 mg/day. Fluoro-deoxyglucose positron emis-
sion tomography/computed tomography (PET-CT) (Fig. S1a, b1) 
showed intense tracer concentration in the peritoneal mass as well 
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Fig. 1. (a) Ulcerations of the tongue. (b) Vesicles and blisters on the trunk. (c) Intercellular deposition and deposition of C3 at the basal intercellular 
substance associated with C3 deposition at the basal membrane zone. (d) Immunoprecipitation on radiolabelled cultured keratinocytes: Lane 1 
(paraneoplastic pemphigus (PNP)): control PNP serum immunoprecipitating the 215 kDa desmoplakin II, the 190 kDa periplakin, and the 170 kDa 
alpha-2-macroglobulin-like-1; Lane 2 (Patient): serum of this patient immunoprecipitating the alpha-2-macroglobulin-like-1. Lane 3 (Normal): normal 
control serum showing no positive reaction.
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as in the thoracic and abdominal lymph nodes, spleen, right lobe 
of the liver, gastric area and, curiously, in the cutaneous plaque 
on the knee. Biopsy of the peritoneal mass revealed a malignant 
neoplasm composed of interconnected bands of medium-large 
sized spindle cells, with hyperchromatic, slightly pleomorphic 
nucleus, inconspicuous nucleoli and eosinophilic cytoplasm. In 
addition, dilated thin-walled vessels at the periphery of the tumour 
with lymphangioma-like areas were associated with an infiltrate of 
lymphocytes and plasma cells (Fig. S2a1). Immunohistochemical 
staining was positive for CD34, CD31 and human herpesvirus 
8 (HHV-8) (Fig. S2b1), leading to a diagnosis of KS. The skin 
biopsy from the knee was re-evaluated and, below the lichenoid 
infiltrate, histological features of KS were detected. HHV-8 was 
also positive in some spindle cells adjacent to dilated vessel walls 
in the deep dermis, suggesting an early phase of KS. The retrope-
ritoneal mass was considered inoperable, and chemotherapy with 
intravenous injection of vincristine 2 mg and cyclophosphamide 
1 g once a week, with doxorubicin 60 mg 4 times a week, was 
introduced. After 3 days, the patient developed severe leukopaenia 
and septic shock (toxic shock syndrome) and eventually died. No 
post-mortem was performed.
DISCUSSION
A diagnosis of PNP/PAMS is based on 3 major criteria 
proposed by Schlesinger et al. (3); (i) polymorphic mu-
cocutaneous eruptions, (ii) concurrent internal neoplasia, 
and (iii) serum antibodies reacting to plectin, desmoplakin 
I and II, bullous pemphigoid antigen I, envoplakin, pe-
riplakin or antigen of 170 kDa; and 3 minor criteria: (i) 
histological evidence of acantholysis, (ii) DIF showing 
intercellular and BMZ staining for IgG and comple-
ment, and (iii) IIF staining with rat bladder epithelium 
for circulating autoantibodies. Of these, PNP/PAMS 
patients should meet at least 3 major, or 2 major and 2 
minor criteria. According to clinical PAMS criteria, our 
patient showed peculiar clinical features and developed 
3 different mucocutaneous variants of the disease during 
its evolution: lichen planus-like lesions at the onset, then 
pemphigus-like lesions and, finally, erythema multiforme-
like lesions with targetoid features (4, 5). Immunologi-
cally, our patient presented the classical criteria of PNP/
PAMS with intercellular deposition of IgG and linear 
deposition of IgG and C3 at the BMZ. IIF on rat bladder 
transitional epithelium showed intercellular deposition 
of IgG autoantibodies, and immunoprecipitation revea-
led reactivity against the alpha-2-macroglobulin-like-1 
protein, which is considered specific to PNP/PAMS. 
Furthermore, anti-A2ML1 autoantibodies appear to be 
associated with early onset of the disease (6). 
PNP/PAMS is associated with different haemolympho-
proliferative neoplasms (84%), such as non-Hodgkin’s 
lymphoma (38.6%), chronic lymphocytic leukaemia 
(18.4%) and Castelman’s disease (18.4%) (7). Solid 
neoplasms have rarely been reported in association with 
PNP/PAMS, with carcinomas in 8.6% of cases and sar-
comas in 6.2% (8). Our patient is the first case of PNP/
PAMS associated with KS to be described in the litera-
ture. Concerning the association with KS, our patient 
tested negative for HIV. The retroperitoneal sarcoma was 
diagnosed only a few weeks after starting prednisone and 
was thus unlikely attributed to drug immunosuppres-
sion. Moreover, an extensive work-up was negative for 
additional malignancies possibly inducing immunosup-
pression. The relationship between PNP/PAMS and the 
neoplasm is still unclear. In patients with thymoma, 
Castleman’s disease and dendritic cell sarcoma, a direct 
role of immune cells in the autoantibodies production 
has been hypothesized. In particular, PNP patients with 
Castleman’s disease, who had several tumour B-cell 
clones producing autoantibodies against desmosomal 
and hemidesmosomal proteins, showed a remarkable 
improvement in symptoms after removal of the tumour. 
Alternatively, the tumour proteins may cross-react with 
PNP epidermal antigens and induce the autoantibody 
production (7). Our case suggests that the tumour may 
also act as a stimulus for the immune system without 
being directly responsible for autoantibody production.
This report highlights the difficulty of diagnosing 
PNP/PAM in its early phase, with extreme polymor-
phism of the skin lesions, and demonstrate a noteworthy 
association with KS characterized by a lichenoid picture 
with early KS findings in the same cutaneous lesion.
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